Kestra Medical Technologies
KMTS
63 hedge funds and large institutions have $1.12B invested in Kestra Medical Technologies in 2025 Q1 according to their latest regulatory filings, with 63 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
90.53% more ownership
Funds ownership: 0% → 90.53% (+91%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCI
Bain Capital Investors
Boston,
Massachusetts
|
+$621M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$73.5M |
| 3 |
YF
Yu Fan
|
+$52.4M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$52.2M |
| 5 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$41.3M |
Top Sellers
KMTS Hedge Fund Activity: Q1 2025 in Review
63 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Kestra Medical Technologies (KMTS) for Q1 2025, worth a combined $1.12B.
Buyers outnumbered sellers: 63 funds opened new KMTS positions and 0 closed out — a net gain of 63 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bain Capital Investors, opening a new position worth an estimated $621M.
- 63 institutional investors held Kestra Medical Technologies (KMTS) as of Q1 2025, up from 0 in Q4 2024.
- Funds reported $1.12B of Kestra Medical Technologies stock for Q1 2025.
- 63 funds opened new Kestra Medical Technologies positions in Q1 2025 and 0 closed out, a net change of +63 holders.
- The largest Kestra Medical Technologies buyer in Q1 2025 was Bain Capital Investors, an estimated $621M added.
Based on aggregated 13F filings for Q1 2025.